0001493152-23-038912.txt : 20231101 0001493152-23-038912.hdr.sgml : 20231101 20231031175547 ACCESSION NUMBER: 0001493152-23-038912 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231031 EFFECTIVENESS DATE: 20231101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspire BioPharma, Inc. CENTRAL INDEX KEY: 0001995528 IRS NUMBER: 660991341 STATE OF INCORPORATION: PR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-496221 FILM NUMBER: 231365969 BUSINESS ADDRESS: STREET 1: 194 CANDELERO DRIVE STREET 2: SUITE 223 CITY: HUMACAO STATE: PR ZIP: 00791 BUSINESS PHONE: (415)-592-7399 MAIL ADDRESS: STREET 1: 194 CANDELERO DRIVE STREET 2: SUITE 223 CITY: HUMACAO STATE: PR ZIP: 00791 D 1 primary_doc.xml X0708 D LIVE 0001995528 Aspire BioPharma, Inc. 194 CANDELERO DRIVE, #223 HUMACAO PR PUERTO RICO 00797 801-427-1111 PUERTO RICO None None Corporation true 2021 Edward Kimball 50 N. Medical Drive Salt Lake City UT UTAH 84132 Director Rodrick Prat 2131 Rabbit Road Wickenburg AZ ARIZONA 85390 Director Stephen Quesenberry 68 East 100 South salem UT UTAH 84653 Executive Officer Director Kraig Higginson 194 Candelero Drive, Apt. 223 Humacao PR PUERTO RICO 00797 Executive Officer Director Ernest scheidemann 355 Heron Avenue Naples FL FLORIDA 34108 Executive Officer Director Pharmaceuticals No Revenues 06c false true false true false 25000 10000000 0 10000000 false 0 0 0 450000 true false Aspire BioPharma, Inc. /s/ Kraig Higginson Kraig Higginson President and CEO 2023-10-31